Moreover, serum FGF21 levels have been shown to predict major cardiac adverse events in humans (88), including non-fatal myocardial infarction, non-fatal stroke, hospitalization due to angina pectoris, and cardiac death. Here, FGF21 is linked to myocardial infarction.